Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EpidStrategies is a scientific consulting firm and Contract Research Organization (CRO) specializing in epidemiology and health outcomes research. As a division of ToxStrategies, the company provides comprehensive services to the pharmaceutical, biotechnology, and medical device sectors, focusing on the generation of real-world evidence (RWE) and systematic scientific reviews. Their core expertise includes conducting meta-analyses, incidence and prevalence studies, and post-marketing safety evaluations to support regulatory submissions and clinical development strategies. By leveraging advanced statistical methods and deep therapeutic area knowledge, EpidStrategies helps clients navigate complex public health challenges and demonstrate the value and safety of their products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EpidStrategies.